330.004 Silicone Gel Breast Implants


Silicone Gel Breast Implants: The Texas Medical Association (1) supports the maintenance of a registry of all patients with breast implants so that data pertaining to health outcomes can be regularly reviewed and reported to physicians and patients; (2) supports that women be fully informed about the risks and benefits associated with breast implants and that once fully informed they have the right to choose whether or not to have the surgery; (3) urges physicians to be informed of the current scientific data and long term studies available; (4) supports appropriate data collection and follow-up in all cases in which such implants are utilized; (5) will monitor the process of decision-making by the Federal Drug Administration (FDA) on the use of not only silicone gel breast implants, but also all silicone-based devices, with particular attention to use of expert medical judgment and to issues of conflict of interest; (6) requests that specific FDA policies regarding the process of evaluation of devices be publicized to the medical profession and the public, and that the process be sensitive to the emotional impact on the patient; and (7) condemns the inappropriate use of laboratory tests that purport to measure the dissemination of silicone through a patient's body and which are used to make unsubstantiated diagnoses of silicone-related illness (CSA, p 132, A-93; substitute CSA Rep. 2-A-03; amended CSPH Rep. 1-A-13).

Last Updated On

October 07, 2016